Loading…

Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents

Saved in:

Bibliographic Details
Published in:	Endocrine 2019-06, Vol.64 (3), p.724-726
Main Authors:	Tucci, Marcello, Roca, Elisa, Ferrari, Laura, Pia, Anna, Dalla Volta, Alberto, Bedussi, Francesca, Buttigliero, Consuelo, Vittorio Scagliotti, Giorgio, Sigala, Sandra, Berruti, Alfredo
Format:	Article
Language:	English
Subjects:	Aged Androstenes - adverse effects Androstenes - therapeutic use Antibodies, Antinuclear - adverse effects Antibodies, Antinuclear - therapeutic use Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Drug Therapy, Combination - adverse effects Endocrinology Humanities and Social Sciences Humans Hypoglycemia Hypoglycemia - chemically induced Hypoglycemic Agents - therapeutic use Internal Medicine Male Medicine Medicine & Public Health multidisciplinary Prednisone Prednisone - adverse effects Prednisone - therapeutic use Prostate cancer Prostatic Neoplasms - complications Prostatic Neoplasms - drug therapy Research Letter Science
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!